Majid, Shehada T.

HRN: 20-46-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/07/2023
02/14/2023
IV
465mg
Q6hours
PCAP-C
Waiting Final Action 
02/10/2023
CEFUROXIME 1.5GM (VIAL)
02/10/2023
02/17/2023
IV
310mg
Q8hrs
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: